Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Equity earnings (loss) in AmerisourceBergen

Impairment of goodwill

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Walgreens

Duane Reade is a subsidiary of Walgreens Boots Alliance, is a chain of pharmacy and convenience stores, primarily located in New York City, known for its high volume small store layouts in densely populated Manhattan locations.

Duane Reade

Boots UK is a pharmacy chain in the United Kingdom, Ireland, Norway, Thailand and other territories. Boots became a subsidiary of the new company, Walgreens Boots Alliance, on 31 December 2014.

Boots UK

Alliance Healthcare was formerly Alliance UniChem, wholesales, distributes, and retails pharmaceutical, surgical, medical, and healthcare products throughout Europe. The company supplies more than 110,000 pharmacies, doctors, health centres and hospitals from over 288 distribution centres in 11 countries. The company is a wholly owned subsidiary of Walgreens Boots Alliance, which was formed by the merger of Walgreens with its former parent Alliance Boots in 2014. Alliance Boots had itself been formed in 2006 by the merger of Boots Group and Alliance UniChem on 31 July 2006. Alliance UniChem was rebranded Alliance Healthcare in 2009.

Alliance Healthcare

Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Walgreens reports Q1 earnings decline, eyes growth opportunities ahead

Walgreens faces challenges from COVID impacts and investments but is on track to achieve full-year guidance.
Strategic acquisitions and scaling U.S. Healthcare present opportunities for growth and profitability.
Despite first-half declines, the company anticipates improvements in margins and performance in the second half.
Efforts to optimize cash flow and investments position Walgreens for future growth and success.

Walgreens reports 4.5% sales growth in Q2 2023 earnings

Walgreens remains cautiously optimistic about managing potential changes in health plans and anticipates a strong second half of the year. The company is targeting debt reduction and small tuck-on acquisitions in healthcare as capital allocation priorities.

Walgreens (WBA) reports mixed Q3 performance, focuses on profitability

Walgreens (WBA) Q3 2023 earnings call highlights mixed performance with a focus on profitability enhancement.
Strategic partnerships, cost management programs, and capital allocation priorities support long-term value creation.
Challenges in margin pressures, script growth, and operational issues require immediate actions for profitability.
Opportunities lie in unlocking profitability, market developments, and demand for risk-based health care services.

Walgreens appoints new CEO to drive cost savings and script growth opportunities

Walgreens is strategically positioning itself for operational efficiency and cost savings in fiscal year 2024. The company's new CEO, Tim Wentworth, is expected to drive healthcare expertise and cost-effective outcomes. Despite challenges like lower contributions and segment declines, Walgreens is leveraging opportunities for script growth and financial improvement.

Walgreens Q1 Earnings: Navigating Challenges, Focused on Value Creation

Walgreens is navigating challenges in the pharmacy sector while focusing on strategic initiatives to drive value creation and sustainable growth. The company's emphasis on partnerships, cost-saving actions, and a shift towards value-based reimbursement models positions them for future success in the evolving healthcare landscape.

Walgreens reports solid Q2 results, focuses on growth strategies

Walgreens navigates retail challenges with strong operational performance. Focus on cost discipline, portfolio optimization, and cash flow improvement. Strategic decisions to drive growth and unlock value in healthcare areas.

Walgreens Q3 Earnings Miss Expectations Amid Challenges

Walgreens' Q3 2024 earnings call highlighted a challenging quarter with missed expectations, driven by pressures in the retail pharmacy sector and adverse market conditions. CEO Tim Wentworth emphasized ongoing strategic reviews and cost management initiatives as key to navigating these challenges. The company remains committed to transforming its business model to better serve customers and improve operational efficiency.

Walgreens (WBA) reports Q4 earnings, focuses on growth strategies

Walgreens (WBA) focused on financial stability, cost efficiency, and strategic growth initiatives in Q4 2024 earnings call.
The company aims to address challenges like disruptions, inflation, and underperforming stores while leveraging strengths in cash flow and cost-cutting.
Opportunities in store optimization, digital enhancement, and asset monetization are key areas for future growth.
Overall, Walgreens is navigating challenges, leveraging strengths, and pursuing opportunities to enhance financial performance and resilience.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Walgreens (WBA) will enable more communities to access reliable, convenient testing services as and when required with the addition of Pixel by LabCorp COVID-19 at-home collection kit.

Walgreens (WBA) Expands Access to COVID-19 Test With LabCorp

NEW YORK--(BUSINESS WIRE)--Results of a new instrumental, skin hydration study show that No7 is outperforming its high-end US competitors with its popular age defying day creams

Iconic British Beauty Brand, No7, Outperforms Prestige Competition in US

DEERFIELD, Ill.--(BUSINESS WIRE)--WBA will release its fiscal 2022 second quarter earnings results at 7 a.m. (Eastern) Thurs., March 31. Conference call begins at 8:30 a.m. (Eastern).

Walgreens Boots Alliance Schedules Fiscal 2022 Second Quarter Earnings Announcement for March 31, 2022

Trulieve Cannabis Corp.

Visa

A reasonably small amount of money can go a long way in these high-quality stocks.

Got $300? 3 No-Brainer Stocks to Buy as the Market Corrects Lower

Walgreens Boots Alliance (WBA) closed the most recent trading day at $46.72, moving +1.24% from the previous trading session.

Walgreens Boots Alliance (WBA) Gains As Market Dips: What You Should Know

GlaxoSmithKline

Merck

Vir Biotechnology

CVS Health

Kroger

Rite Aid

President Joe Biden announced during his State of the Union address on Tuesday that individuals who test positive for Covid-19 at a pharmacy will soon be able to get free antiviral treatments immediately after. The cost will be funded by the federal government, which could result in a huge boost to the revenue of companies in the pharmaceutical, pharmacy and diagnostic industries over the coming year.

Health Care Stocks to Watch as Test to Treat Plan Looks to Prevent Lockdowns

Moderna

Pfizer

Thermo Fisher Scientific

President Joe Biden announced during his State of the Union address on Tuesday that individuals who test positive for Covid-19 at a pharmacy will soon be able to get free antiviral treatments immediately after. The cost will be funded by the federal government, which could result in a huge boost to the revenue of companies in the pharmaceutical, pharmacy, and diagnostic industries over the coming year.

Test to Treat Plan can Boost these Stocks

American Eagle Outfitters

Dow Inc

Innovative Industrial Properties

International Paper

Kontoor Brands Inc

Morgan Stanley

Newell Brands

Simon Property Group

"This indiscriminate selling has created many stocks with absurdly high yields that also happen to be dirt-cheap on an earnings basis," Cramer said Wednesday.

Jim Cramer says these 10 high-yielding dividend stocks should be on your shopping list

Curaleaf Holdings, Inc.

Medtronic

Even a small investment in these stocks can go a long way.

3 Supercharged Stocks to Buy With $1,000 Right Now

The multibillion-pound sale of U.K. drugstore Boots has been derailed after a possible buyer walked away and several bidders raised concerns about financing a deal in the midst of Russia's invasion into Ukraine, Financial Times reported Tuesday (March 1). A consortium of Bain Capital and CVC Capital, which had been the leading candidate to buy […]

Sale of Walgreen's Boots in Flux in UK With Less Bidders, Market Upset

Amgen

Boeing

Caterpillar

Salesforce

Chevron

Disney

Goldman Sachs

Intel

JPMorgan Chase & Co

Coca-Cola

Microsoft

NIKE

Verizon

"The Dow® [adds a stock] if the company has an excellent reputation, demonstrates sustained growth, and is of interest to a large number of investors. Sector representation is also a consideration."

Dogs Of The Dow For March Drop Closer To Buy Points

Stocks are being pressured in 2022 due to the Fed's tapering, possible interest rate hikes, and conflict in Ukraine.

3 Beaten Down Stocks Yielding 4%

Unilever

They all pay high yields -- and they're all on sale.

3 of the Best Dividend Stocks to Buy for March 2022

Same-day delivery service Shipt announced in a Friday (Feb. 25) press release that it has launched partnerships with pharmacy chain Walgreens and convenience store 7-Eleven, marking more than 140 collaborations with retailers. “Located on corners of nearly every major market in America, these two powerhouse brands are incredible complements to our marketplace, bringing customers even […]

Shipt Launches Walgreens, 7-Eleven Partnership

Air Products and Chemicals

Atmos Energy

Franklin Resources

Chubb

Clorox

Cintas Corp

Ecolab

Nucor

PPG Industries

Stanley Black & Decker

Sysco

T. Rowe Price Group

V.F.

NOBL starts the year on a sour note losing 4.08% in January.

My Best Dividend Aristocrats For March 2022

Realty Income Corp

IBM, Realty Income, and Walgreens are three of our favorite high yield names that we believe can provide the income that investors desire without some of the risks that other high yield sources carry. The post 3 Dividend Aristocrats That Offer High Yields appeared first on InvestorPlace.

3 Dividend Aristocrats That Offer High Yields

Britain's largest drugstore chain Boots has set a Feb. 24 deadline to receive indicative bids from a series of deep-pocketed investors that could value the 173-year old firm at up to 8 billion pounds ($10.88 billion), two sources told Reuters.

Boots in store for $10 billion sale as bid deadline looms

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced the release of its fiscal 2021 Environmental, Social and Governance 2021 (ESG) Report, which outlines the company's commitment to its four corporate responsibility pillars – Healthy Communities, Healthy Planet, Healthy and Inclusive Workplace and Sustainable Marketplace – all at the heart of its purpose to create more joyful lives through better health. The Report highlights the company's work in heal

Walgreens Boots Alliance Releases Latest ESG Report

Palo Alto Networks

When crashes and corrections rear their head, so does the opportunity for investors.

The Smartest Stocks to Buy if the Stock Market Plunges

Con Ed

Federal Realty Investment Trust

Johnson & Johnson

Procter & Gamble

While most of the attention this past week has been focused on the potential for a conflict between Ukraine and Russia, the real problem for investors are the mounting inflation pressures, now at the highest levels in over 40 years.

5 Very Safe Dividend Aristocrats to Buy Now: Massive Sell-Off Could Be Coming Soon

DEERFIELD, Ill. & CHICAGO--(BUSINESS WIRE)--Walgreens and VillageMD announce opening of five new Village Medical at Walgreens primary care practices in the Jacksonville area through summer 2022.

Walgreens and VillageMD Expand in Florida with Five New Full-Service, Primary Care Practices Opening in Jacksonville

News for Walgreens Stock (WBA)